CLINICAL_TRIALS
trial_result
· 2024-05-01
Clinical Trial Update: A Study of CC-99677 in Participants With Active Ankylosing Spondylitis [Phase 2]
Summary
A Phase 2 trial of CC-99677 in active ankylosing spondylitis was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Spondylitis, Ankylosing | Phase 2 | Status: TERMINATED | Results posted: 2024-05-01